XML 24 R9.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities      
Net earnings $ 363,735 $ 269,096 $ 175,810
Adjustments to reconcile net earnings to net cash provided by operating activities:      
Depreciation and amortization 100,876 92,021 91,153
Write-off of assets relating to restructuring and other exit charges 1,973 24,229 8,920
Impairment of goodwill 880 0 0
Loss on assets held for sale 4,634 13,619 480
Derivatives not designated in hedging relationships:      
Net losses (gains) (3,136) 846 (1,182)
Cash proceeds (settlements) 826 (255) 470
Provision for doubtful accounts 3,239 1,873 (431)
Deferred income taxes (31,925) (29,344) (15,236)
Non-cash interest expense 1,927 2,450 1,964
Stock-based compensation 27,825 30,607 26,371
Gain on disposal of property, plant, and equipment 791 908 (113)
Gain on pension settlement (1,548) 0 0
Changes in assets and liabilities, net of effects of acquisitions:      
Accounts receivable (81,795) 108,631 67,553
Inventories 1,343 75,633 (96,413)
Prepaid and other current assets (220,003) (112,701) 23,689
Other assets (334) 6,027 (6,298)
Accounts payable 36,569 (15,131) (4,236)
Accrued expenses 54,388 (8,254) 5,747
Other liabilities 32 (3,226) 1,690
Net cash provided by (used in) operating activities 260,298 457,029 279,938
Cash flows from investing activities      
Capital expenditures (121,038) (86,437) (88,772)
Purchase of businesses (206,374) (8,270) 0
Proceeds from disposal of property, plant, and equipment 1,870 2,228 586
Investment in Equity Securities (10,852) 0 0
Proceeds from termination of net investment hedges 0 0 43,384
Net cash used in investing activities (336,394) (92,479) (44,802)
Cash flows from financing activities      
Net borrowings (repayments) on short-term debt (259) (231) (21,719)
Proceeds from Second Amended Revolver borrowings 650,000 182,500 310,500
Repayments of Second Amended Revolver borrowings (370,000) (427,500) (500,500)
Proceeds from Amended 2017 Term Loan 0 0 300,000
Proceeds from 2032 Bonds 0 300,000 0
Repayments of 2023 Senior Notes 0 0 (300,000)
Repayments of Second and Third Amended Term Loan 0 293,889 5,215
Debt issuance costs 0 (4,061) (1,121)
Finance lease obligations and other 483 1,169 1,110
Option proceeds, net 9,458 10,786 4,392
Payment of taxes related to net share settlement of equity awards (7,985) (9,166) (6,453)
Purchase of treasury stock (153,961) (95,688) (22,907)
Dividends paid to stockholders (37,466) (34,480) (28,537)
Net cash (used in) provided by financing activities 90,270 (370,560) (270,450)
Effect of exchange rate changes on cash and cash equivalents (4,367) (7,331) (20,509)
Net (decrease) increase in cash and cash equivalents 9,807 (13,341) (55,823)
Cash and cash equivalents at beginning of year 333,324 346,665 402,488
Cash and cash equivalents at end of year $ 343,131 $ 333,324 $ 346,665